See All Slides - tctmd.com

Slides

Presentation TVT 2019

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Presenter: Josep Rodés-Cabau

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Preliminary Data on Hemodynamic Outcomes After Sapien ULTRA

Presenter: Rebecca Hahn

June 13, 2019

Presentation TVT 2019

Advanced Design Features, Implantation Tips and Tricks, and Future Vision

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Implementation of Multidisciplinary Team Approach to the Management of Patients with Mitral and Tricuspid Valve Disease

Presenter: Mohanad Hamandi

June 13, 2019

Presentation TVT 2019

Case: JenaValve for Pure Aortic Regurgitation

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Pericardial Effusion After Left Atrial Appendage Closure: Lessons Learned From the MAUDE Database

Presenter: Christopher Sossou

June 13, 2019

Presentation TVT 2019

6-Month Outcomes from the Multicenter, Prospective Study With the Novel PASCAL Transcatheter Mitral Repair System for Patients With Mitral Regurgitation

Presenter: Scott Lim

June 13, 2019

Presentation TVT 2019

Distribution of Effective Regurgitant Orifice Area and Regurgitant Volume Compared to Left Ventricular End-Diastolic Volume in a Cohort of Patients With Secondary Mitral Regurgitation

Presenter: Anna Sannino

June 13, 2019

Advertisement

Slides

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

3 Illustrative Cases (Optimal Valve Sizing, Managing Severe AV/LVOT Calcification, and Coronary Access Issues) – A Case-Based Discussion

Preliminary Data on Hemodynamic Outcomes After Sapien ULTRA

Advanced Design Features, Implantation Tips and Tricks, and Future Vision

Implementation of Multidisciplinary Team Approach to the Management of Patients with Mitral and Tricuspid Valve Disease

Case: JenaValve for Pure Aortic Regurgitation

Pericardial Effusion After Left Atrial Appendage Closure: Lessons Learned From the MAUDE Database

6-Month Outcomes from the Multicenter, Prospective Study With the Novel PASCAL Transcatheter Mitral Repair System for Patients With Mitral Regurgitation

Distribution of Effective Regurgitant Orifice Area and Regurgitant Volume Compared to Left Ventricular End-Diastolic Volume in a Cohort of Patients With Secondary Mitral Regurgitation

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content